Institute of Liver and Biliary Sciences (ILBS)

The Institute of Liver and Biliary Sciences (ILBS) represents a sophisticated paradigm shift in the Indian healthcare and medical education landscape. Established in 2009 by the Government of the National Capital Territory (NCT) of Delhi, it functions as an autonomous mono-superspeciality institution under the Societies Registration Act, 1860. Its inception was driven by the recognition that liver and biliary diseases require a dedicated, high-intensity focus that general multi-specialty hospitals often struggle to provide at the requisite scale. By concentrating exclusively on the "hepato-pancreato-biliary highway," ILBS has cultivated a unique environment where clinical excellence, advanced research, and specialized education converge. As a Deemed-to-be-University under Section 3 of the University Grants Commission (UGC) Act, ILBS has transcended its primary role as a tertiary care hospital to become a premier academic hub, often referred to within its community as "Yakrit-Kutumbakam"—the Liver Family.

Structural Governance and Institutional Vision

The governance of ILBS is designed to balance public accountability with the operational flexibility required of a cutting-edge medical center. The institute is overseen by a Governing Council and several specialized committees, including the Project Review Committee, the Institutional Ethics Committee, and the Scientific Advisory Committee. This multi-tiered oversight ensures that clinical protocols, research initiatives, and expansion projects are aligned with international standards of safety and efficacy.

The institutional vision is articulated through four foundational pillars: clinical specialities, university-level education, innovative research, and community outreach. This holistic approach is intended to serve as a "torch-bearer model" for healthcare in India, amalgamating the academic structure of traditional universities with the clinical acumen of super-specialists and the efficient managerial practices of the corporate world. The quality statement of the institute underscores a commitment to evidence-based clinical practices, transparent management, and the protection of patient dignity and rights.

Educational Landscape and National Rankings

The standing of ILBS within the Indian educational hierarchy is validated by its performance in major national ranking frameworks. Since its establishment, the institute has demonstrated a consistent upward trajectory, reflecting improvements in its teaching methodologies, research output, and graduation outcomes.

National Institutional Ranking Framework (NIRF) Analysis

In the 2025 National Institutional Ranking Framework (NIRF) cycle, ILBS achieved the 28th position in the 'Medical' category, marking a significant advancement from its 34th rank in 2024. This improvement is largely attributed to exceptional scores in Teaching, Learning, and Resources (TLR), which reached 85.08, and Graduation Outcomes (GO), recorded at 54.95.

The data indicates that while ILBS excels in core academic delivery and infrastructure, its "Perception" score remains a critical area for future growth. ILBS must continue to build its brand recognition among the broader public beyond the specialized medical community, especially when compared to legacy institutions like the All India Institute of Medical Sciences (AIIMS) Delhi, which has a perception score of 100.00. However, when evaluated specifically as a medical university, India Today positioned ILBS at the 8th rank nationally in 2025, a testament to its stability and reputation within its niche.

Indian Institutional Ranking Framework (IIRF) Standings

The Indian Institutional Ranking Framework (IIRF) provides another lens through which to view the institute's competitive positioning. In 2025, ILBS was ranked 38th in the IIRF Deemed University category and had previously held positions such as 29th in the Medical category in 2023. These rankings highlight the institute's ability to compete effectively against much larger, multi-faculty universities despite its highly specialized focus.

Academic Programs and Pedagogical Framework

The academic portfolio of ILBS is meticulously structured to address the specific human resource needs of high-end hepatobiliary and transplant centers. As a Deemed University, it offers a broad spectrum of courses, ranging from short-term certificate programs to doctorate-level degrees.

Super-Specialty Medical Programs (DM and MCh)

The flagship programs of the institute are the three-year residential Doctorate of Medicine (DM) and Master of Chirurgiae (MCh) degrees. These programs are designed to produce consultants who possess both deep clinical knowledge and the surgical or interventional skills required for complex procedures such as liver transplantation.

Doctoral (PhD) and Post-Doctoral Certificate Courses (PDCC)

The institute recognizes the need for specialized training for medical professionals who have already completed their post-graduation. The one-year Post-Doctoral Certificate Courses (PDCC) are particularly noted for their depth in specific sub-domains.

• PDCC Organ Transplant Anaesthesia: Focuses on the unique physiological challenges of patients undergoing liver and renal transplants.

• PDCC Interventional Radiology: Trains radiologists in advanced hepatobiliary interventions such as TIPS (transjugular intrahepatic portosystemic shunt) and TACE (transarterial chemoembolization).

• PDCC Hepatopathology: Dedicated to the microscopic diagnosis of liver diseases, which is essential for managing transplant rejection and complex tumors.

• PDCC Pediatric Hepatology: Addresses the specific diagnostic and management protocols for childhood liver diseases.

The PhD programs at ILBS are focused on translating laboratory findings into clinical practice. Specialized PhD tracks are offered in Molecular and Cellular Medicine, Clinical Nutrition, Virology, and the Epidemiology of Viral Hepatitis.

Allied Health and Nursing Programs

The ILBS College of Nursing plays a critical role in the institute's ecosystem by offering an M.Sc. in Nursing. This program is tailored to produce nursing specialists capable of operating in high-dependency units (HDUs) and transplant ICUs, where 1:1 nurse-to-patient ratios are frequently required.

Admission Protocols and Eligibility Framework

The admission process at ILBS is rigorous, ensuring that only candidates with high academic potential and clinical aptitude are selected. The methodology varies depending on the level of the program and national-level requirements.

Admission to Super-Specialty Courses (DM/MCh)

Admissions for DM and MCh programs are conducted through the National Eligibility cum Entrance Test for Super Specialties (NEET SS), administered by the National Board of Examinations (NBE). Candidates must participate in a centralized counseling process based on their national rank. The cutoffs for these programs are among the most competitive in India, reflecting the institute's status as a top-tier destination for medical graduates.

PhD and Certificate Program Admissions

For PhD, PDCC, and Post-Graduate Certificate Courses (PGCC), ILBS conducts its entrance examinations. These examinations are typically held twice a year, ensuring a regular intake of researchers and trainees. The selection for PhD candidates is particularly comprehensive, involving a written qualifying test (70% weightage) and a personal interview (30% weightage).

PhD Weightage and Selection Matrix:

• CSIR/UGC-NET JRF/ICMR-JRF Qualification: Candidates with national-level fellowships are awarded 30 marks and are often exempted from the written test, moving directly to the interview phase.

• Research Experience: A minimum of six months of relevant research experience is valued at 20 marks.

• Research Presentation: Candidates must deliver a 10-minute presentation on their proposed research or past work (10 marks).

• Interview Performance: Evaluated for communication skills, depth of knowledge, and alignment with faculty research areas (40 marks).

General Eligibility and Application Modalities

Eligibility for the majority of postgraduate programs requires a recognized medical degree (MBBS/MD/MS/DNB) with valid registration from the National Medical Commission (NMC). For non-medical PhD tracks, a Master’s degree (M.Sc.) in a relevant field with at least 60% aggregate marks is required. Applications are submitted online via the ILBS website, with application fees ranging from INR 1,000 for certificate courses to INR 2,500 for super-specialty programs.

Departmental Architecture and Clinical Services

The organizational structure of ILBS is divided into clinical, laboratory, and research wings, each working in a synergistic manner to support the institute’s mission.

Core Clinical Departments

The clinical wings are focused on providing both medical and surgical management for complex organ system failures.

• Department of Hepatology: This is the clinical heart of the institute, managing patients with cirrhosis, acute-on-chronic liver failure (ACLF), and viral hepatitis. It operates a specialized 24/7 GI Bleed unit strategically located near the endoscopy suite to minimize transport time for critical patients.

• HPB Surgery and Liver Transplantation: This department has achieved significant milestones, including the completion of over 1,000 successful liver transplants. It performs living donor, deceased donor, and complex pediatric transplants.

• Pediatric Hepatology: India's first dedicated unit for children with liver diseases, addressing conditions such as biliary atresia and metabolic liver disorders.

• Nephrology and Renal Transplant: This department extends the institute's transplant expertise to kidney diseases, having performed over 250 renal transplants.

• Anaesthesia and Critical Care: Managing one of the most advanced transplant ICUs in the country, this department specializes in the perioperative management of patients with end-stage organ diseases.

Laboratory Medicine and Diagnostic Support

The laboratories at ILBS are accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL) and equipped with high-throughput automated systems.

• Clinical Virology: Focuses on the molecular kinetics of HBV, HCV, and HEV, providing quantitative viral load testing and genotyping.

• Hepatopathology: Specializes in liver histology, providing rapid intraoperative consultations (frozen sections) for transplant graft viability.

• Clinical and Cellular Transplant Immunology: Vital for managing histocompatibility and monitoring for graft-versus-host disease (GVHD) or rejection.

The Research Ecosystem: Labs, Innovation, and Patents

Research at ILBS is not a secondary activity but a core institutional mission. The Research Department is designed to bridge the "bench to bedside" gap, ensuring that basic science findings are rapidly integrated into patient care.

Specialized Research Laboratories

The institute maintains several state-of-the-art facilities, many established through national and international collaborations.

• ILBS-NIH Laboratory of Molecular Immunology: A core facility established in partnership with the National Institutes of Health (USA) to accelerate research into the immunological basis of liver failure and sepsis.

• National Liver Disease Biobank (NLDB): A Department of Biotechnology (DBT)-funded initiative that serves as a national repository for biological samples (HCV/HBV tissues and fluids). It provides a platform for longitudinal cohort studies and supports multi-centric research across India.

• Hepatic Regenerative Medicine Lab: Focuses on native liver repair and developing cell-based therapies, such as mesenchymal stem cell (MSC) and macrophage therapy, to prevent bioenergetic exhaustion in patients with liver failure.

• Metabolome and Metagenomics Laboratory: Established in collaboration with INSERM (France) to study the role of the gut-liver axis and the microbiome in disease progression.

Pre-Clinical and Imaging Infrastructure

The "Global Star" project, funded by DBT, led to the establishment of the Pre-Clinical In-Vivo Imaging Facility at ILBS. This facility is equipped with an IVIS Lumina XRMS III system, which allows researchers to non-invasively track tumor growth, stem cell migration, and drug pharmacokinetics in animal models using bioluminescence and fluorescence. The institute also has a Center for Comparative Medicine (animal house) with BSL-3 containment facilities for research on dangerous pathogens.

Technological Innovations and Intellectual Property

ILBS actively engages in translational science, resulting in several patents and drug candidates. A notable success is the development of IR-415 (and its DSA-00 derivatives), a thiourea drug that targets HBV DNA replication with high efficacy and low toxicity in cell models; a patent has been filed for this technology. The institute also explores medical device innovation, including biomedical sensors and diagnostic tools, often inviting senior engineers and technology leads for these specialized projects.

Infrastructure: Strategic Expansion and Technological Capacity

The physical infrastructure of ILBS is divided into Phase I and Phase II blocks, reflecting a phased growth strategy managed by the Public Works Department (PWD) and the Delhi Metro Rail Corporation (DMRC).

Capacity and Specialized Units

The institute's total sanctioned capacity is 549 beds, with over 300 currently operational. A defining feature of ILBS is its high ratio of critical care beds—nearly 50% of the total bed strength is dedicated to ICU and HDU facilities.

The six modular operating suites are equipped with cutting-edge surgical technology, including ultrasonic surgical aspirators, cell savers, rapid infusion systems, and argon beam coagulators. Two ORs are strictly dedicated to transplant surgery, while the others handle complex HPB and urological procedures. Phase II also introduced a high-tech auditorium, a guest house for international trainees, and additional residential quarters for faculty.

International Tie-ups, Collaborations, and Community Outreach

ILBS operates as a global node for liver sciences, maintaining active collaborations with world-class medical and research organizations.

Academic and Research Partnerships

• APASL School of Hepatology: ILBS is the home of the Asian Pacific Association for the Study of the Liver (APASL) school, providing advanced training to clinicians from the Asia-Pacific region.

• WGO and WHO Partnerships: The institute serves as a training center for World Gastroenterology Organisation (WGO) trainees and works with the World Health Organization (WHO) on technical consultations regarding viral hepatitis.

• Swiss National Science Foundation (SNSF): Collaborative "One Health" research projects involving Indian and Swiss scientists focused on antimicrobial resistance (AMR) and zoonotic diseases.

• INSERM and INRA (France): Joint laboratories for studying gut microbiota and its systemic impact on hepatic health.

Community Outreach and Digital Health

ILBS leverages technology to extend its expertise beyond the national capital.

• Project ILBS ECHO: Uses the Extension for Community Healthcare Outcomes (ECHO) model—a hub-and-spoke virtual mentorship program—to train primary care physicians in the management of hepatitis and cirrhosis.

• Project Empathy: A national campaign aimed at reducing the social stigma faced by patients with Hepatitis B and C, often in partnership with the Airports Authority of India (AAI).

• Telemedicine and Virtual OPD: To ensure continuity of care, the institute operates a virtual OPD via WhatsApp, allowing patients from across India and abroad to consult with super-specialists.

Financial Sustainability and Funding Mechanisms

As an autonomous institution under the GNCTD, ILBS receives primary budgetary support for its operational and capital expenditures from the state government. However, a diverse range of extramural grants sustain its research and innovation agenda.

• State Funding: The GNCTD Finance Committee, chaired by the Principal Secretary (Finance), provides oversight for large-scale expansions like the INR 497 crore Phase II project.

• Central Government Grants: Substantial funding is received from the Department of Biotechnology (DBT), the Department of Science and Technology (DST), and the Indian Council of Medical Research (ICMR) for specific laboratory setups and research trials.

• Research Service Revenue: ILBS generates internal revenue by offering its high-end diagnostic and pre-clinical facilities to external government and private institutions on a chargeable basis. For example, the in-vivo imaging facility is available to external private investigators at a rate of INR 6,000 per hour plus GST.

Employability and Career Trajectories

Graduates and trainees from ILBS are among the most specialized medical professionals in the world. The "mono-superspeciality" focus ensures that they possess technical skills that are in high demand globally.

Placement Success and Top Recruiters

According to NIRF 2023 and 2024 reports, the institute has maintained a placement rate between 73% and 100% for its graduating cohorts. The median salary for placed graduates has shown a steady increase, reaching INR 47 Lakhs per annum in the most recent academic cycles.

Top recruiters for ILBS alumni include:

• Premier public institutions like AIIMS Delhi and other national AIIMS branches.

• Leading private hospital chains such as Apollo Hospitals, Max Healthcare, Fortis Healthcare, and Medanta - The Medicity.

• Diagnostic and research giants like SRL Diagnostics and Artemis Hospitals.

Alumni Base and The "Liver University" Legacy

The ILBS Alumni Association (ILBSAA) serves as a bridge between the institute and its graduates, who now occupy leadership positions in transplant units across the globe. The institute organizes regular alumni meets to reflect on the legacy of excellence and nostalgically reconnect with the "roots" of their specialized training.

The concept of the "Liver University" emphasizes that the learning process at ILBS is not limited to degrees but is a lifelong commitment to scientific inquiry. Notable figures within the Indian healthcare sector, including Dr. Shiv Kumar Sarin, have underscored the role of alumni as ambassadors of the ILBS "quality of care" model.

The Institute of Liver and Biliary Sciences has successfully demonstrated that a specialized hospital-university model can achieve results far exceeding general healthcare structures. Its high research output (RPC scores), exceptional placement outcomes, and the achievement of 1,000 liver transplants solidify its position as a global center of excellence.

The future growth of the institute will likely come from completing Phase II, which will add a helipad for emergency transplant transport and expand the high-containment research areas. The institute is still a key part of India's medical and scientific infrastructure. It is still filing patents for new antivirals and running national-level outreach programs like the ECHO project. The integration of high-level clinical services with a rigorous academic and research ecosystem ensures that ILBS will continue to be a leader in the global fight against hepatobiliary diseases.

FAQs

1. What is the full form of ILBS?

    It stands for the Institute of Liver and Biliary Sciences.

2. Where is ILBS located?

    It is located in Sector D-1, Vasant Kunj, New Delhi, India.

3. When was ILBS established?

    The institute was established in 2009 by the Government of the National Capital Territory (NCT) of Delhi.

4. Is ILBS a government or private institute?

    It is an autonomous institute under the Government of NCT of Delhi and functions as a public/government institution.

5. What is its status as a university?

    ILBS is a "Deemed-to-be-University" under Section 3 of the University Grants Commission (UGC) Act.

6. Is ILBS accredited?

    Yes, it is accredited by the National Accreditation Board for Hospitals & Healthcare Providers (NABH) and has a Grade ‘A’ accreditation from NAAC.

7. What is the NIRF ranking of ILBS in 2025?

    ILBS achieved the 28th rank in the 'Medical' category in the 2025 National Institutional Ranking Framework (NIRF).

8. How has its NIRF ranking changed recently?

    It improved significantly from the 34th rank in 2024 to the 28th rank in 2025.

9. What is its IIRF ranking?

    In 2025, ILBS was ranked 38th in the Indian Institutional Ranking Framework (IIRF) Deemed University category.

10. How does India Today rank the institute?

    India Today ranked ILBS 8th among the top "Medical Universities" in India in 2024 and 2025.

11. Does ILBS offer an MBBS program?

    No, ILBS does not offer an MBBS program; it focuses exclusively on super-specialty, doctoral, and post-doctoral medical education.

12. What are the flagship DM courses offered?

    Flagship DM programs include Hepatology, Organ Transplant Anaesthesia & Critical Care, and Pediatric Hepatology.

13. Which MCh program is available?

    ILBS offers a 3-year MCh in Hepato-Pancreato-Biliary (HPB) Surgery.

14. What PhD tracks are available at ILBS?

    PhD programs are offered in Molecular and Cellular Medicine, Clinical Nutrition, Virology, and the Epidemiology of Viral Hepatitis.

15. How many total academic programs does ILBS offer?

    The institute offers approximately 26 different academic programs across various levels.

16. What is a PDCC?

    PDCC stands for Post-Doctoral Certificate Course, which is a one-year specialized training program for post-graduates.

17. What is a PGCC?

    PGCC stands for Post-Graduate Certificate Course, offered in fields like Clinical Nutrition and Dialysis Therapy.

18. Does ILBS have a nursing college?

    Yes, the ILBS College of Nursing offers an M.Sc. in Nursing.

19. What is the admission criteria for DM and MCh programs?

    Admission is strictly based on the National Eligibility cum Entrance Test for Super Specialties (NEET SS) scores and centralized counseling.

20. How are PhD candidates selected?

    Selection involves an ILBS-conducted written qualifying test (70% weightage) and a personal interview (30% weightage).

21. Are any candidates exempt from the PhD entrance exam?

    Yes, candidates who have cleared national-level fellowships like CSIR/UGC-NET JRF, DBT-JRF, or ICMR-JRF can directly appear for the interview.

22. What is the eligibility for DM Hepatology?

    Candidates must hold an MD/DNB in General Medicine or Pediatrics.

23. What is the eligibility for MCh HPB Surgery?

    Candidates must hold an MS/DNB in General Surgery.

24. When do academic sessions typically start?

    PhD and certificate courses often start in January, while DM and MCh courses usually begin in July.

25. Is the application process online?

    Yes, applications for all programs must be submitted online through the official ILBS website.

26. What is the application fee?

    The fee is approximately INR 2,500 for super-specialty courses and INR 1,000 for PhD and PG certificate programs.

27. What is the annual tuition fee for DM/MCh courses?

    The annual fee for these flagship programs is approximately INR 70,000.

28. How much does a PhD program cost at ILBS?

    The tuition fee is approximately INR 14,000 to INR 20,000 per year.

29. Do residents receive a stipend?

    Yes, DM and MCh residents receive a monthly stipend of approximately INR 1.2 to 1.5 Lakhs.

30. What are the fees for certificate courses (PDCC/PGCC)?

    Fees for these courses range from approximately INR 25,000 to INR 80,000 per year depending on the specialization.

31. What is the total bed capacity of the hospital?

    The total sanctioned capacity is 549 beds, with over 300 currently operational.

32. What is unique about ILBS Phase II?

    Phase II added a dedicated research complex, an auditorium, a guest house, and an additional 100 ICU beds.

33. Does ILBS have dedicated ICU units?

    Yes, it has specialized ICUs for Liver Coma, Surgical ICU, Liver Transplant ICU, and Renal Transplant ICU.

34. What is the "GI Bleed Unit"?

    It is a specialized 24/7 unit located near the endoscopy suite for immediate management of high-risk bleeding patients.

35. Does the institute have a library?

    Yes, ILBS has a comprehensive physical library and an e-library for its students and faculty.

36. Are there hostel facilities?

    Yes, hostel accommodation is provided for students enrolled in long-term academic programs.

37. What is the National Liver Disease Biobank (NLDB)?

    Funded by the DBT, it is a national repository for biological samples (HCV/HBV) to facilitate longitudinal medical research.

38. Does ILBS have a high-containment lab?

    Yes, the institute houses a state-of-the-art Biosafety Level 3 (BSL-3) research facility.

39. What is the Pre-clinical In-Vivo Imaging Facility?

    It is a specialized center equipped with IVIS Lumina technology for non-invasive tracking of drug efficacy and tumor growth in research models.

40. Are there any medical patents held by ILBS?

    The institute has filed patents for novel thiourea drugs (like IR-415) aimed at inhibiting HBV replication.

41. What is Project ILBS ECHO?

    A virtual mentorship program using tele-health to train primary care doctors in managing chronic liver diseases.

42. What is Project Empathy?

    A national campaign to reduce the social stigma associated with Hepatitis B and C.

43. Does ILBS collaborate internationally?

    Yes, it has active tie-ups with the NIH (USA), INSERM (France), and various institutions in Korea and Nepal.

44. What is the APASL School of Hepatology?

    It is a specialized training hub hosted at ILBS in collaboration with the Asian Pacific Association for the Study of the Liver.

45. What is the median salary for placed PG graduates?

    According to 2023-24 NIRF reports, the median salary was INR 47 Lakhs per annum.

46. What is the placement percentage?

   ILBS typically sees a placement rate between 73% and 100% for its graduating super-specialists.[27, 10]

47. Who are the top recruiters for ILBS alumni?

    AIIMS, Apollo Hospitals, Max Healthcare, Fortis, and Medanta frequently recruit graduates.

48. Does the institute have an Alumni Association?

    Yes, the ILBS Alumni Association (ILBSAA) maintains a network of former students globally.

49. Who is the prominent founder figure mentioned in reports?

    Dr. Shiv Kumar Sarin is a Senior Professor and a key visionary behind the institute's academic and clinical model.

50. What does the term "Yakrit-Kutumbakam" mean?

    It translates to "The Liver Family," symbolizing the institute’s unified focus on liver health and welfare.